Reconstruction surgery rarely discussed with breast cancer patients

December 21, 2007

A new study finds that most general surgeons do not discuss reconstruction with patients before surgical breast cancer treatment. The analysis shows that only one in three patients eligible for mastectomy or breast conserving surgery have such discussions. The study is published in the February 1, 2008 issue of CANCER, a peer-reviewed journal of the American Cancer Society.

The option of breast reconstruction has increased treatment choices for women with breast cancer. Women with early stage disease who are not likely to need post-mastectomy radiation are considered eligible for reconstruction at the time of surgery. However, little is known about how often surgeons discuss breast reconstruction with patients.

Led by Dr. Amy Alderman of the University of Michigan Medical Center, researchers surveyed a 1,178 women aged 79 years or younger who had undergone a surgical procedure for stage I, II, or III breast cancer between December 2001 to January 2003.

The researchers found only 33 percent of patients had a general surgeon discuss breast reconstruction with them during the surgical decision-making process for their cancer. Surgeons were significantly more likely to have this discussion with younger, more educated patients. Patients who discussed reconstruction with their surgeon were more willing to consider having a mastectomy and were more than 4 times likely to undergo the surgery. The findings suggest that discussing reconstruction will impact women's decisions regarding initial surgery for their breast cancer.

According to the authors, these results have important implications for patient care and policy. "This research suggests that patients should be informed of all options in order to be educated consumers of healthcare and ensure maximal breast cancer treatment decision quality," they conclude. "Our results suggest a need for comprehensive breast cancer treatment decision aids, including information on initial surgery and other treatment options such as reconstruction."
-end-
Article: "Understanding the Impact of Breast Reconstruction on the Surgical Decision-Making Process for Breast Cancer" Amy K. Alderman, Sarah T. Hawley, Jennifer Waljee, Mahasin Mujahid, Monica Morrow, and Steven J. Katz. CANCER; Published Online: December 21, 2007 (DOI: 10.1002/cncr.23214); Print Issue Date: February 1, 2008.

Contact: Nicole Fawcett, University of Michigan Comprehensive Cancer Center, 734-764-2220, nfawcett@umich.edu

Wiley

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.